Home » Topics » BioWorld Science

BioWorld Science
RSS

Synlogic begins phase I study of SYNB-1934 for phenylketonuria

July 16, 2021

Compugen studies COM-902 in combination with COM-701 for advanced malignancies in phase I

July 16, 2021

Dosing underway in phase I study of IBI-319 in advanced malignant tumors

July 16, 2021

BetterLife's AP-003 shows in vitro antiviral activity against SARS-CoV-2

July 16, 2021

Phase II trial evaluates combination of VIR-2218 and VIR-3434 for chronic hepatitis B

July 16, 2021

KRIBB-11 controls molecular pathways with potential for therapeutic strategy for glioblastoma

July 16, 2021

H3Mab-17 significantly reduces tumor growth in mouse model of colorectal adenocarcinoma

July 16, 2021

IL-1alpha inhibition reduces hyperinflammation in a COVID-19 murine model

July 16, 2021

Novel PIV5-based mucosal vaccine protects mice and ferrets against SARS-CoV-2 challenge

July 16, 2021

Tumor suppressor p53 is inactivated by lncRNA

July 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...